User: Guest  Login
Title:

[New therapy concepts for castration-resistant prostate cancer: between hormone manipulation, targeted therapy and chemotherapy].

Document type:
English Abstract; Journal Article
Author(s):
Kübler, H; Miller, K
Abstract:
Within the last 2 years the therapeutic landscape of castration-resistant prostate cancer (CRPC) has dramatically changed. While chemotherapy with docetaxel has only shown a survival benefit in CRPC patients in the last 10 years, in the meantime 4 approved drugs are available for this indication and approval for immunotherapy with sipuleucel-T is expected. Docetaxel still plays a significant role in the treatment of CRPC but is also a cesura in the therapeutic sequence. For asymptomatic or minim...     »
Journal title abbreviation:
Urologe A
Year:
2013
Journal volume:
52
Journal issue:
11
Pages contribution:
1517-8, 1520-1, 1524-6 pa
Language:
de
Fulltext / DOI:
doi:10.1007/s00120-013-3247-9
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/24166056
Print-ISSN:
0340-2592
TUM Institution:
Urologische Klinik und Poliklinik
 BibTeX